Literature DB >> 31804407

Neuraxial Labor Analgesia Utilization, Incidence of Postdural Puncture Headache, and Epidural Blood Patch Placement for Privately Insured Parturients in the United States (2008-2015).

Carlos Delgado1, Laurent Bollag, Wil Van Cleve.   

Abstract

BACKGROUND: Neuraxial analgesia is the gold standard for labor analgesia in the United States, and postdural puncture headache (PDPH) is one of the most common complications. PDPH is frequently treated with an epidural blood patch (EBP), but conservative treatment approaches remain common. Our current understanding of the incidence of PDPH and the frequency of EBP utilization is heavily based on reports from academic medical centers. We studied a private insurance database to provide estimates of neuraxial labor analgesia (NLA) use and PDPH and EBP incidence in the United States.
METHODS: Labor and delivery insurance claims from the Truven MarketScan Commercial Claims and Encounters database were analyzed. Mode of delivery, analgesic and/or operative anesthesia information, and EBP placement were identified using Current Procedural Terminology (CPT) codes. PDPH was identified using International Classification of Diseases, Ninth Revision (ICD-9) codes.
RESULTS: The analytic dataset consisted of 1,752,243 deliveries. Vaginal deliveries (VD) comprised 64.6% of the sample. Of these, 72.9% received NLA, with a PDPH incidence of 0.58% (95% confidence interval [CI], 0.57-0.60). Using VD with NLA as a referent, the risk ratio for PDPH following cesarean delivery (CD) without a prior NLA was 1.1 (95 CI, 1.05-1.15; P = .0001), while the risk ratio for PDPH following CD with a prior NLA was 0.81 (95% CI, 0.76-0.87; P < .0001). EBP placement was documented in 68.4% PDPH cases following VD with NLA, 67.2% of PDPH cases following CD with prior NLA, and 59.7% of PDPH cases following CD without prior NLA. The median number of days between delivery and first and EBP was 3. A second EBP was performed in 8.3% of initially patched patients, and a third in 0.1%. In patients who went on to receive a repeat EBP, the median interval between delivery and the first EBP was 1 day.
CONCLUSIONS: This analysis confirms findings of prior studies regarding the present utilization of neuraxial analgesia and the incidence of PDPH. When compared to patients undergoing VD with NLA, patients having CD without NLA had a higher incidence of PDPH, presumably due to intentional dural puncture. Women having CD with a prior NLA had a lower incidence of PDPH, possibly due to avoidance of pushing during the second stage of labor. EBP was a commonly pursued strategy for the treatment of PDPH and was more commonly pursued in patients with a history of NLA. Repeat EBP was rare.

Entities:  

Mesh:

Year:  2020        PMID: 31804407     DOI: 10.1213/ANE.0000000000004561

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  All epidural needle bevels are not the same.

Authors:  Amber C Benhardt; Bhavani Shankar Kodali
Journal:  Indian J Anaesth       Date:  2021-04-15

2.  [Postdural puncture headache in obstetrics : Pathogenesis, diagnostics and treatment].

Authors:  Benedikt Hermann Siegler; Beatrice Oehler; Peter Kranke; Markus Alexander Weigand
Journal:  Anaesthesiologie       Date:  2022-07-14

Review 3.  Health equity research in obstetric anesthesia.

Authors:  Olubukola Toyobo; Jean Guglielminotti; Doerthe Adriana Andreae; Michael H Andreae
Journal:  Curr Opin Anaesthesiol       Date:  2022-06-01       Impact factor: 2.733

4.  Racial and Ethnic Disparities in the Management of Postdural Puncture Headache With Epidural Blood Patch for Obstetric Patients in New York State.

Authors:  Allison Lee; Jean Guglielminotti; Anne-Sophie Janvier; Guoha Li; Ruth Landau
Journal:  JAMA Netw Open       Date:  2022-04-01

5.  Analgesic Effects, Birth Process, and Prognosis of Pregnant Women in Normal Labor by Epidural Analgesia Using Sufentanil in Combination with Ropivacaine: A Retrospective Cohort Study.

Authors:  Lijing Mao; Xiaoxiao Zhang; Jing Zhu
Journal:  Comput Intell Neurosci       Date:  2022-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.